Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Thrombophilia D019851 6 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Ogundaini A et al. Isolation of two new antiinflammatory biflavanoids from Sarcophyte piriei. 1996 J. Nat. Prod. pmid:8786365
Baker RR Enzymes of platelet activating factor synthesis in brain. 1995 Neurochem. Res. pmid:8786821
Yoshii H et al. Neurotropin inhibits accumulation of eosinophils induced by allergen through the suppression of sensitized T-cells. 1995 Int. J. Immunopharmacol. pmid:8788117
Battye KM et al. Ovine endometrium synthesizes and releases platelet-activating factor, which can cause the release of prostaglandin F2 alpha by the uterus in situ. 1996 Biol. Reprod. pmid:8788186
Hirafuji M et al. Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro. 1996 Br. J. Pharmacol. pmid:8789382
Bazan NG and Allan G Platelet-activating factor is both a modulator of synaptic function and a mediator of cerebral injury and inflammation. 1996 Adv Neurol pmid:8790822
Naraba H et al. Inhibitory effect of arachidonic acid on platelet-activating factor production in rat neutrophils. 1996 Eur. J. Pharmacol. pmid:8790999
Aïssa J et al. Biochemical and cellular effects of heparin-protamine injection in rabbits are partially inhibited by a PAF-acether receptor antagonist. 1996 Eur. J. Pharmacol. pmid:8791000
Weikert LF and Bernard GR Pharmacotherapy of sepsis. 1996 Clin. Chest Med. pmid:8792067
Takeda H et al. Release of fructose and hexose phosphates from perivascular cells induced by low density lipoprotein and acceleration of protein glycation in vitro. 1996 Diabetes Res. Clin. Pract. pmid:8792096
Abebe W et al. Platelet-activating factor-induced inositol 1,4,5-trisphosphate generation in undifferentiated and differentiated U937 cells: role of tyrosine kinase. 1996 Int. J. Immunopharmacol. pmid:8796445
Parent JL et al. Identification of transmembrane domain residues determinant in the structure-function relationship of the human platelet-activating factor receptor by site-directed mutagenesis. 1996 J. Biol. Chem. pmid:8798529
Marcheselli VL and Bazan NG Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist. 1996 J. Biol. Chem. pmid:8798751
van Rossem K et al. The role of PAF and the effect of a specific PAF antagonist on local tissue PO2 and neuronal integrity during and after photothrombotic brain infarction in unanesthetised rabbits. 1996 Adv. Exp. Med. Biol. pmid:8798843
Westmoreland SV et al. Toxicity of TNF alpha and platelet activating factor for human NT2N neurons: a tissue culture model for human immunodeficiency virus dementia. 1996 J. Neurovirol. pmid:8799203
Civelli M et al. The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363. 1996 Br. J. Pharmacol. pmid:8799563
Noguchi K et al. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs. 1996 Br. J. Pharmacol. pmid:8799566
Marrakchi N et al. [Biochemical and pharmacologic properties of platelet aggregants and platelet antiaggregants of viper venoms in Tunisia]. 1994 Jul-Oct Arch Inst Pasteur Tunis pmid:8801850
Catalán RE et al. Nitric oxide mediates the PAF-stimulated cyclic GMP production in hippocampal slices. 1996 Biochem. Biophys. Res. Commun. pmid:8806587
Baskin SI et al. The effects of EDRF/NO releasers or calcium ionophore A23187 on cyanide toxicity in mice. 1996 Toxicol. Appl. Pharmacol. pmid:8806852
Dunlop ME et al. Production of hyaluronan by glomerular mesangial cells in response to fibronectin and platelet-derived growth factor. 1996 Kidney Int. pmid:8807570
Arima S et al. Platelet-activating factor dilates efferent arterioles through glomerulus-derived nitric oxide. 1996 J. Am. Soc. Nephrol. pmid:8808114
Tachibana F et al. Platelet-activating factor and leukotrienes in acute otitis media, secretory otitis media, and chronic otitis media on the acute excerbation. 1996 Auris Nasus Larynx pmid:8809319
Yasugahira H et al. [The changes of blood gas analysis values and platelet aggregability on acute phase in the experimental model of pulmonary embolism prepared by sephadex G-75 (SG-75) injection]. 1996 Nihon Kyobu Shikkan Gakkai Zasshi pmid:8810754
Durán WN et al. Platelet-activating factor modulates leukocyte adhesion to endothelium in ischemia-reperfusion. 1996 Microvasc. Res. pmid:8812764
Tao Y et al. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium. 1996 Invest. Ophthalmol. Vis. Sci. pmid:8814143
Erger RA and Casale TB Eosinophil migration in response to three molecular species of platelet activating factor. 1996 Inflamm. Res. pmid:8814455
Sato E et al. Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity. 1996 J. Immunol. pmid:8816423
Bauldry SA and Wooten RE Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation. 1996 Biochim. Biophys. Acta pmid:8816854
Le Texier L et al. Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity. 1996 J Lipid Mediat Cell Signal pmid:8816984
Le Texier L et al. Structure-activity relationships in platelet-activating factor (PAF). 8. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors: anti-acetylcholinesterase activity and comparative SAR. 1996 J Lipid Mediat Cell Signal pmid:8816985
Le Solleu H et al. A pharmacophore for high affinity PAF antagonists. I. Electronic model using molecular electrostatic potential. 1996 J Lipid Mediat Cell Signal pmid:8816988
Abu-Zidan FM and Walther S Platelet activating factor antagonism improves cardiovascular function in non-hypotensive sepsis in pigs. 1996 Eur J Surg pmid:8817228
Lin J et al. Effects of platelet-activating factor (PAF) receptor blockage on mucous glycoprotein secretion in cultured chinchilla middle ear epithelium. 1996 Acta Otolaryngol. pmid:8820353
Kuitert L and Barnes NC PAF and asthma--time for an appraisal? 1995 Clin. Exp. Allergy pmid:8821294
Miguélez R et al. Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis. 1996 J Lipid Mediat Cell Signal pmid:8821809
Murakami K et al. A novel platelet activating factor antagonist, SM-12502, attenuates endotoxin-induced disseminated intravascular coagulation and acute pulmonary vascular injury by inhibiting TNF production in rats. 1996 Thromb. Haemost. pmid:8822594
Yang HO et al. Biological and pharmacological effects of pinusolide, a novel platelet activating factor antagonist. 1995 Planta Med. pmid:8824945
Predescu D et al. The vascular distribution of the platelet-activating factor receptor. 1996 Eur. J. Cell Biol. pmid:8825027
Burt RP et al. The role of diacylglycerol and activation of protein kinase C in alpha 1A-adrenoceptor-mediated contraction to noradrenaline of rat isolated epididymal vas deferens. 1996 Br. J. Pharmacol. pmid:8825367
Grinyó JM et al. The role of platelet-activating factor antagonists in the prophylaxis of posttransplant acute tubular necrosis. 1996 Ren Fail pmid:8827990
López-Novoa JM et al. The role of platelet-activating factor and the effect of PAF blocking receptors on the outcome of ARF. 1996 Ren Fail pmid:8827995
Spangelo BL and Jarvis WD Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro. 1996 Endocrinology pmid:8828503
Galloway SW and Kingsnorth AN Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist. 1996 Pancreas pmid:8829181
Sandoval D et al. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. 1996 Gastroenterology pmid:8831604
Ribaldi E et al. Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation. 1996 Br. J. Pharmacol. pmid:8832056
Savu SR et al. Determination of 1-O-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, platelet-activating factor and related phospholipids in biological samples by high-performance liquid chromatography--tandem mass spectrometry. 1996 J. Chromatogr. B, Biomed. Appl. pmid:8832423
Tsukioka K et al. Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma. 1996 Jan-Feb J Investig Allergol Clin Immunol pmid:8833165
Matsuo Y et al. Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain. 1996 Brain Res. pmid:8833766
Gabryelewicz A Etiology and pathogenesis of acute pancreatitis--current view. 1995 Rocz. Akad. Med. Bialymst. pmid:8834603